Stay updated on Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page’s footer revision/version was updated from **v3.5.2** to **v3.5.3**, reflecting a minor release of the website interface.
    Difference
    0.0%
    Check dated 2026-04-24T22:23:59.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T14:07:56.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Page revision updated: v3.5.0 added and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-20T00:18:57.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision label in the page footer was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T21:09:38.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1; no substantive changes to the study page content are evident.
    Difference
    0.0%
    Check dated 2026-02-12T01:50:28.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.4.1 added and v3.4.0 removed on the site; no impact on study details or documents. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:42:29.000Z thumbnail image

Stay in the know with updates to Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.